Tasly Capital
Asia, Guangdong, China, Tianjin'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Tasly Capital is an investment arm of Tasly, a Chinese pharmaceutical company.
Investor Profile
Tasly Capital has backed more than 5 startups, with 2 new investments in the last 12 months alone. The firm has led 2 rounds, about 40% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series C rounds (top funding stages).
- Majority of deals are located in China.
- Strong thematic focus on Medical, Biotechnology, Health Care.
- Led 2 rounds in the past year.
Stage Focus
- Series B (40%)
- Series A (40%)
- Series C (20%)
Country Focus
- China (100%)
Industry Focus
- Medical
- Biotechnology
- Health Care
- Manufacturing
- Medical Device
- Biopharma
- Pharmaceutical
- Hospital
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Tasly Capital frequently co-invest with?
What are some of recent deals done by Tasly Capital?
Find More Investors Like Tasly Capital
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
